Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders
- PMID: 3204397
- PMCID: PMC1033190
- DOI: 10.1136/jnnp.51.7.893
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders
Abstract
Leukocyte glutamate dehydrogenase (GDH) activity was measured in 39 normal subjects, 32 neurological controls, 66 patients with progressive ataxic disorders, 32 with multiple system atrophy, 40 with Parkinson's disease, eight with Steele-Richardson-Olszewski syndrome, eight with juvenile Parkinsonism and four with the dystonia-Parkinsonism syndrome. GDH activity was reproducible to within 10% in leukocyte pellets stored at -70 degrees C for up to 9 months, and did not vary with sex or age in control subjects. There was marked variation in the relative proportions of heat stable and heat labile forms of GDH between control subjects and on repeated assay in the same subject. Total leukocyte GDH activity was similar in normal subjects and neurological controls. Mean total GDH activity was reduced in all patient groups by between 15 to 29% compared with controls. Fourteen patients had total GDH activity below 50% of the control mean, but low values were not specific for any one disease (five had ataxic disorders, four Parkinson's disease, three multiple system atrophy, one juvenile Parkinsonism, and one dystonia-Parkinsonism). The heat labile fraction of GDH represented about 20% of total activity in control subjects, and 27% in the patients with reduced total GDH activity. Thus low GDH activity was not disease-specific in this study, and the heat-labile GDH fraction was not selectively affected. "Reduced" leucocyte GDH activity in some patients may represent no more than the lower end of a normal distribution.
Similar articles
-
Low leukocyte glutamate dehydrogenase activity does not correlate with a particular type of multiple system atrophy.J Neurol Neurosurg Psychiatry. 1988 Dec;51(12):1508-11. doi: 10.1136/jnnp.51.12.1508. J Neurol Neurosurg Psychiatry. 1988. PMID: 3221218 Free PMC article.
-
Decreased glutamate dehydrogenase protein in spinocerebellar degeneration.J Neurol Neurosurg Psychiatry. 1988 Aug;51(8):1078-80. doi: 10.1136/jnnp.51.8.1078. J Neurol Neurosurg Psychiatry. 1988. PMID: 3216208 Free PMC article.
-
Leukocyte glutamate dehydrogenase and CSF amino acids in late onset ataxias.Acta Neurol Scand. 1990 Oct;82(4):225-9. doi: 10.1111/j.1600-0404.1990.tb01610.x. Acta Neurol Scand. 1990. PMID: 2270751
-
Glutamate dehydrogenase deficiency in cerebellar degenerations: clinical, biochemical and molecular genetic aspects.Can J Neurol Sci. 1993 May;20 Suppl 3:S109-16. Can J Neurol Sci. 1993. PMID: 8334586 Review.
-
Glutamate Dehydrogenase as a Neuroprotective Target Against Neurodegeneration.Neurochem Res. 2019 Jan;44(1):147-153. doi: 10.1007/s11064-018-2467-1. Epub 2018 Jan 22. Neurochem Res. 2019. PMID: 29357018 Review.
Cited by
-
DIDMOAD syndrome; further studies and muscle biochemistry.J Inherit Metab Dis. 1995;18(2):218-20. doi: 10.1007/BF00711771. J Inherit Metab Dis. 1995. PMID: 7564251 No abstract available.
-
Multiple system degeneration with glutamate dehydrogenase deficiency: pathology and biochemistry.J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1099-101. doi: 10.1136/jnnp.53.12.1099. J Neurol Neurosurg Psychiatry. 1990. PMID: 1705575 Free PMC article.
-
Leukocyte glutamate dehydrogenase in patients with degenerative neurological disorders.J Neurol Neurosurg Psychiatry. 1989 Mar;52(3):424. doi: 10.1136/jnnp.52.3.424. J Neurol Neurosurg Psychiatry. 1989. PMID: 2926437 Free PMC article. No abstract available.
-
Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.J Neurol Neurosurg Psychiatry. 1991 Nov;54(11):984-8. doi: 10.1136/jnnp.54.11.984. J Neurol Neurosurg Psychiatry. 1991. PMID: 1686899 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical